beta

ALXO

ALX Oncology Holdings, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia on April 1, 2020 and is headquartered in Burlingame, CA.

Market Cap: 1.58 Billion

Primary Exchange: NASDAQ

Website: http://alxoncology.com

Shares Outstanding: 36.5 Million

Float: 17.6 Million

Dividend: (%)

Beta: -0.939459692137222

Sector: Commercial Services

Industry: Miscellaneous Commercial Services

Ethical Flags

Longest drawdown: 4 trading days

From: 2020-07-21 To: 2020-07-27

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud